Cancer Radiotherapy Equipment
-
Manufactured by VUP Medical, a.s.based in CZECH REPUBLIC
ARAVEL medical underwear is designed for cancer patients after radiotherapy who suffer from a consultative skin reaction, either in the form of erythema or consultative dermatitis. It is made of polypropylene fibers, which give it lightness and breathability. The use of this product can help in the management of deliberative changes and ...
-
Manufactured by Lipella Pharmaceuticals Inc.based in USA
The following is a link to the Radiation Cystitis Patient Registry. If you are a cancer survivor with a history of pelvic radiation therapy, please consider joining the registry. The potential uses of this registry about radiation cystitis and hemorrhagic cystitis (and cancer survivorship post-radiotherapy) include: improving the ...
-
Manufactured by Hitachi America, Ltd.based in USA
Hitachi provides a Hybrid particle therapy system which can irradiate both proton and carbon-ion from one ...
-
Manufactured by Curasightbased in DENMARK
Curasight's uTREAT is new type of targeted radiation therapy, targeting and irradiating the cancer cells and almost not healthy tissue. By injecting a substance that seeks all cancer cells, including the metastases that are far away from the primary tumour, this offers a personalised and tailored therapy to each ...
-
Manufactured by Galera Therapeutics, Inc.based in USA
to normal tissue in a variety of organs. Avasopasem received Breakthrough Therapy and Fast Track Designations from the U.S. Food and Drug Administration for the reduction of the incidence and severity of radiation induced oral mucositis in head and neck cancer. Avasopasem has completed two randomized trials, both of which met the primary ...
-
by Accuraybased in USA
Image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) featuring integrated 3D image guidance, and highly conformal treatments enabled by a unique binary MLC. ...
-
Manufactured by Cancer Targeted Technologybased in USA
CTT’s lead therapeutic product, CTT1403, is a PSMA-targeted 177Lu-labeled agent for prostate cancer that can has superior binding characteristics, long circulation half-life, enhanced tumor uptake and unparalleled anti-tumor efficacy. CTT1403 will specifically deliver the radionuclide, 177Lu, minimizing toxic side effects and ...
-
Manufactured by Nanostics Inc.based in CANADA
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
-
Manufactured by Nanostics Inc.based in CANADA
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 patient clinical study designed to meet regulatory ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you